State Street’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-921,691
Closed -$152M 4761
2021
Q2
$152M Sell
921,691
-537,594
-37% -$89.7M 0.01% 1007
2021
Q1
$224M Buy
1,459,285
+3,033
+0.2% +$412K 0.01% 746
2020
Q4
$183M Buy
1,456,252
+28,298
+2% +$3.16M 0.01% 781
2020
Q3
$145M Sell
1,427,954
-76,970
-5% -$7.85M 0.01% 802
2020
Q2
$146M Buy
1,504,924
+20,164
+1% +$1.88M 0.01% 774
2020
Q1
$123M Buy
1,484,760
+48,704
+3% +$4.75M 0.01% 756
2019
Q4
$160M Sell
1,436,056
-1,524
-0.1% -$157K 0.01% 790
2019
Q3
$143M Buy
1,437,580
+26,075
+2% +$2.59M 0.01% 808
2019
Q2
$140M Buy
1,411,505
+28,116
+2% +$2.68M 0.01% 846
2019
Q1
$153M Buy
1,383,389
+39,358
+3% +$4.11M 0.01% 768
2018
Q4
$124M Sell
1,344,031
-107,813
-7% -$10.9M 0.01% 800
2018
Q3
$160M Buy
1,451,844
+177,322
+14% +$18.5M 0.01% 799
2018
Q2
$119M Buy
1,274,522
+294,728
+30% +$25.4M 0.01% 920
2018
Q1
$81.3M Sell
979,794
-41,300
-4% -$3.67M 0.01% 1115
2017
Q4
$93M Buy
1,021,094
+56,888
+6% +$4.73M 0.01% 1051
2017
Q3
$73.4M Buy
964,206
+181,406
+23% +$13.7M 0.01% 1154
2017
Q2
$58.7M Buy
782,800
+270,530
+53% +$18.8M 0.01% 1265
2017
Q1
$33.4M Buy
512,270
+62,898
+14% +$3.7M ﹤0.01% 1574
2016
Q4
$24.8M Buy
449,372
+27,107
+6% +$1.49M ﹤0.01% 1737
2016
Q3
$23.9M Buy
422,265
+35,235
+9% +$1.73M ﹤0.01% 1666
2016
Q2
$16.2M Buy
387,030
+47,651
+14% +$2.2M ﹤0.01% 1908
2016
Q1
$14.5M Buy
339,379
+14,585
+4% +$616K ﹤0.01% 1936
2015
Q4
$14.7M Buy
324,794
+19,517
+6% +$820K ﹤0.01% 1943
2015
Q3
$11.9M Buy
305,277
+6,237
+2% +$250K ﹤0.01% 2078
2015
Q2
$10.9M Buy
299,040
+34,571
+13% +$1.09M ﹤0.01% 2212
2015
Q1
$7.63M Buy
264,469
+60,067
+29% +$1.68M ﹤0.01% 2351
2014
Q4
$4.95M Buy
+204,402
New +$4.61M ﹤0.01% 2574

Other funds holding PRAH